Creo Medical Acquires Albyn Medical for $29.3m

Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves. The acquisition expands Creo’s GI product suite and provides an entry into Urology. Deal value -- $29.3m upfront plus an additional $3.2m in milestones on EBITDA of $2.8m (10.5x).

Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare mergers, Medical Devices, Endoscopy, Urology, Gastroenterology